Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider

QUANTUM-SI ANNOUNCES NEW EXECUTIVE TEAM MEMBERS TO ACCELERATE THE EVOLUTION OF THE COMPANY INTO A LEADING PROTEOMIC TOOL PROVIDER Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Todd Bennett will join QSI as the Company’s new Chief Commercial Officer effective September 17, 2024, John Vieceli, Ph.D. has […]

Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

BRANFORD, Conn.–(BUSINESS WIRE)–Aug. 26, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the 26th Annual H.C. Wainwright Global Investment Conference taking place in New York City September 9-11, 2024. Jeff Hawkins, Quantum-Si’s Chief Executive Officer, will participate in a fireside chat on […]

Quantum-Si Reports Second Quarter 2024 Financial Results

Announces Release of Version 3 Sequencing Kit Announces Two Additional Kit Launches Expected by End of 2024 BRANFORD, Conn.–(BUSINESS WIRE)–Aug. 7, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the second quarter ended June 30, 2024.   Press Release Highlights   Reported revenue of […]

Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference

BRANFORD, Conn.–(BUSINESS WIRE)–Jul. 30, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the Canaccord Genuity 44th Annual Growth Conference taking place in Boston August 13-15, 2024. Jeff Hawkins, Quantum-Si’s Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will participate in […]

Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024

BRANFORD, Conn.–(BUSINESS WIRE)–Jul. 17, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the second quarter of 2024 on Wednesday, August 7, 2024. Company management will host a conference call to discuss financial results and provide a business update on the […]

Quantum-Si Announces Presentation on the Use of Next-Generation Protein Sequencing™ to Detect Disease-Relevant Proteoforms at the Festival of Genomics and Biodata

BRANFORD, Conn.–(BUSINESS WIRE)–Jun. 10, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a presentation by Gloria Sheynkman, Ph.D., Assistant Professor in the Department of Molecular Physiology and Biological Physics at the University of Virginia at the Festival of Genomics and Biodata conference being held in Boston on […]

Quantum-Si Announces Presentations at ASMS and ESHG

BRANFORD, Conn.–(BUSINESS WIRE)–May 31, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced presentations at two upcoming industry conferences. Gloria Sheynkman, PhD, Assistant Professor in the Department of Molecular Physiology and Biological Physics at the University of Virginia’s lab will present a poster developed in collaboration with Quantum-Si […]

Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors

BRANFORD, Conn.–(BUSINESS WIRE)–May 30, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Charles (“Chuck”) Kummeth to the role of independent Chairman of the Board, effective May 27, 2024. Mr. Kummeth has over 35 years of leadership experience in Life Sciences most recently as President […]

Quantum-Si Reports First Quarter 2024 Financial Results

Executed Full Commercial Launch of Platinum® Instrument Reaffirms Full Year 2024 Financial Guidance BRANFORD, Conn.–(BUSINESS WIRE)–May 9, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the first quarter ended March 31, 2024. Press Release Highlights Reported revenue of $457,000 in the first quarter of […]

Quantum-Si Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time

BRANFORD, Conn.–(BUSINESS WIRE)–Apr. 30, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced upgrades to its Platinum® Analysis Software to reduce processing time and increase output and precision of Next-Generation Protein Sequencing™ (NGPS) data from the Platinum® instrument. “A core component of our Platinum Analysis Software is a […]